Perioperative Treatment of Resectable Adenocarcinoma of Esophagogastric Junction by Immunotherapy (Adebrelimab) Combined With Chemotherapy (XELOX): a Prospective, Single-center, Feasibility Study

Name: Perioperative Treatment of Resectable Adenocarcinoma of Esophagogastric Junction by Immunotherapy (Adebrelimab) Combined With Chemotherapy (XELOX): a Prospective, Single-center, Feasibility Study
License: Public Domain

Ruijin Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

esophagogastric junction adenocarcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 390903
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.